# FDA 483 - Ursa Brown-Glaberman - December 19, 2025

Source: https://www.globalkeysolutions.net/records/483/ursa-brown-glaberman/6a5ea1a7-b5b6-4265-8f28-45bafe2b0fc2

> FDA 483 for Ursa Brown-Glaberman on December 19, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ursa Brown-Glaberman
- Inspection Date: 2025-12-19
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Ursa Brown-Glaberman in Albuquerque, NM, identified a significant issue related to clinical trial conduct. The firm failed to promptly report serious adverse events (SAEs) to the study sponsor for multiple participants, indicating a lapse in adherence to protocol requirements for timely safety reporting.

## Related Officers

- [Melissa S. Mcguinness](https://www.globalkeysolutions.net/people/melissa-s-mcguinness/5a7054ba-be7b-488a-a244-294b85c33d0b)

Company: https://www.globalkeysolutions.net/companies/ursa-brown-glaberman/402895c6-584a-467e-9467-df2d23e55ec9

Office: https://www.globalkeysolutions.net/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face